| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 142,7 k € | +74.0% | 82,0 k € | -8.6% | 89,7 k € | +23.8% | 72,5 k € | -52.1% | 151,4 k € | +127.5% | 66,6 k € | +473.3% | 11,6 k € | -17.7% | 14,1 k € | +164.3% | -22,0 k € | -167.4% | 32,6 k € | -40.0% | 54,3 k € | -15.0% | 63,8 k € | +42.6% | 44,8 k € | +14.8% | 39,0 k € | -5.7% | 41,4 k € | -6.2% | 44,1 k € | -0.7% | 44,4 k € | -76.4% | 187,8 k € | -18.4% | 230,0 k € | |
| EBITDA | 141,7 k € | +74.7% | 81,1 k € | -8.7% | 88,9 k € | +24.2% | 71,6 k € | -52.5% | 150,7 k € | +128.4% | 66,0 k € | +529.4% | 10,5 k € | -9.6% | 11,6 k € | +143.0% | -27,0 k € | -187.6% | 30,8 k € | -37.6% | 49,4 k € | -20.4% | 62,0 k € | +45.2% | 42,7 k € | +14.7% | 37,2 k € | -6.2% | 39,7 k € | -6.4% | 42,4 k € | +0.0% | 42,4 k € | -77.3% | 186,5 k € | -18.1% | 227,7 k € | |
| Operating profit | 136,1 k € | +116.6% | 62,8 k € | -11.0% | 70,6 k € | +31.9% | 53,5 k € | -60.6% | 136,0 k € | +155.2% | 53,3 k € | +840.5% | -7,2 k € | -3.3% | -7,0 k € | +84.9% | -46,2 k € | -603.8% | 9,2 k € | -63.9% | 25,3 k € | -53.7% | 54,7 k € | +88.5% | 29,0 k € | +30.6% | 22,2 k € | -12.8% | 25,5 k € | -11.4% | 28,8 k € | -3.2% | 29,7 k € | -82.8% | 172,9 k € | -21.9% | 221,3 k € | |
| Profit/loss | 98,6 k € | +130.2% | 42,8 k € | -12.7% | 49,1 k € | +32.4% | 37,1 k € | -60.8% | 94,6 k € | +101.3% | 47,0 k € | +702.6% | -7,8 k € | -9.4% | -7,1 k € | +86.0% | -50,9 k € | -568.3% | 10,9 k € | -90.4% | 113,6 k € | +172.6% | 41,7 k € | +86.4% | 22,4 k € | +25.6% | 17,8 k € | -13.1% | 20,5 k € | -6.2% | 21,8 k € | -19.0% | 26,9 k € | -79.0% | 128,5 k € | -15.4% | 151,9 k € | |
| Equity | 374,4 k € | +35.8% | 275,8 k € | +18.4% | 232,9 k € | +26.7% | 183,8 k € | +25.3% | 146,8 k € | +78.8% | 82,1 k € | -44.8% | 148,7 k € | -55.0% | 330,6 k € | -2.1% | 337,7 k € | -13.1% | 388,6 k € | +2.9% | 377,7 k € | +43.0% | 264,2 k € | +9.2% | 241,9 k € | +9.8% | 220,3 k € | +8.8% | 202,5 k € | +11.2% | 182,0 k € | +13.6% | 160,2 k € | +20.2% | 133,3 k € | -56.3% | 304,8 k € | |
| Total assets | 408,8 k € | +32.9% | 307,5 k € | +9.3% | 281,2 k € | +20.0% | 234,3 k € | -10.0% | 260,3 k € | -4.4% | 272,1 k € | +67.1% | 162,8 k € | -54.4% | 356,9 k € | -1.4% | 361,8 k € | -9.9% | 401,5 k € | -12.3% | 457,7 k € | +57.1% | 291,3 k € | +8.4% | 268,7 k € | +11.6% | 240,9 k € | +6.1% | 227,0 k € | +7.3% | 211,6 k € | +3.2% | 205,0 k € | -55.7% | 463,2 k € | +24.5% | 372,2 k € | |
| Cash | 76,0 k € | +13.2% | 67,1 k € | -61.3% | 173,4 k € | +53.7% | 112,8 k € | -6.4% | 120,6 k € | -39.8% | 200,4 k € | +43.2% | 139,9 k € | -54.9% | 310,1 k € | +4.2% | 297,6 k € | -5.4% | 314,6 k € | -10.4% | 351,2 k € | +70.6% | 205,8 k € | +3.4% | 199,0 k € | +24.2% | 160,3 k € | +10.7% | 144,8 k € | +46.4% | 99,0 k € | -3.4% | 102,5 k € | +457.8% | 18,4 k € | -39.2% | 30,2 k € | |
| Debts | 34,4 k € | +8.3% | 31,7 k € | -34.3% | 48,3 k € | -4.3% | 50,5 k € | -55.5% | 113,5 k € | -40.3% | 190,0 k € | +1258.1% | 14,0 k € | -46.8% | 26,3 k € | +9.2% | 24,1 k € | +86.2% | 12,9 k € | -83.8% | 79,9 k € | +195.1% | 27,1 k € | +0.9% | 26,8 k € | +30.7% | 20,5 k € | -15.9% | 24,4 k € | -17.2% | 29,5 k € | -33.0% | 44,0 k € | -86.7% | 329,9 k € | +389.4% | 67,4 k € | |
Private limited company · Hove · incorporated on 11/06/1991
Private limited company profitable and well capitalised. Cash position rising (+13.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PROMACON is a Private limited company incorporated in 1991. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Hove.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette